Article Details

Omicron-specific Sinopharm COVID vaccine candidates cleared for clinical trial - Moneycontrol

Retrieved on: 2022-04-16 20:20:22

Tags for this article:

Click the tags to see associated articles and topics

Omicron-specific Sinopharm COVID vaccine candidates cleared for clinical trial - Moneycontrol. View article details on hiswai:

Excerpt

Representative image. Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were ...

Article found on: www.moneycontrol.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up